Kendler KS, Karkowski LM, Neale MC, Prescott CA. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry. 2000;57(3):261–9.
Article
CAS
PubMed
Google Scholar
Uhl GR, Liu QR, Naiman D. Substance abuse vulnerability loci: converging genome scanning data. Trends Genet. 2002;18(8):420–5.
Article
CAS
PubMed
Google Scholar
Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet. 2005;6(7):521–32.
Article
CAS
PubMed
Google Scholar
Volkow N, Li TK. The neuroscience of addiction. Nat Neurosci. 2005;8(11):1429–30.
Article
CAS
PubMed
Google Scholar
Kerdsan W, Thanoi S, Nudmamud-Thanoi S. Changes in the neuronal glutamate transporter EAAT3 in rat brain after exposure to methamphetamine. Basic Clin Pharmacol Toxicol. 2012;111(4):275–8.
CAS
PubMed
Google Scholar
Joyce JN, Renish L, Osredkar T, Walro JM, Kucera J, Dluzen DE. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Synapse. 2004;52(1):11–9.
Article
CAS
PubMed
Google Scholar
Mark KA, Soghomonian JJ, Yamamoto BK. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J Neurosc. 2004;24(50):11449–56.
Article
CAS
Google Scholar
Yamamoto BK, Bankson MG. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit Rev Neurobiol. 2005;17(2):87–117.
Article
CAS
PubMed
Google Scholar
Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci. 1998;18(13):4861–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Blakely RD, Bauman AL. Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol. 2000;10(3):328–36.
Article
CAS
PubMed
Google Scholar
Robinson MB. Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J Neurochem. 2002;80(1):1–11.
Article
CAS
PubMed
Google Scholar
Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry. 2001;158(3):377–82.
Article
CAS
PubMed
Google Scholar
Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry. 2001;158(8):1206–14.
Article
CAS
PubMed
Google Scholar
Ujike H, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y, Sora I, Iyo M, Katsu T, Nomura A, et al. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J. 2003;3(4):242–7.
Article
CAS
PubMed
Google Scholar
Bousman CA, Glatt SJ, Everall IP, Tsuang MT. Genetic association studies of methamphetamine use disorders: a systematic review and synthesis. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(8):1025–49.
Article
CAS
PubMed
Google Scholar
Matsuzawa D, Hashimoto K, Miyatake R, Shirayama Y, Shimizu E, Maeda K, Suzuki Y, Mashimo Y, Sekine Y, Inada T, et al. Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Am J Psychiatry. 2007;164(7):1105–14.
Article
PubMed
Google Scholar
Stober G, Meyer J, Nanda I, Wienker TF, Saar K, Knapp M, Jatzke S, Schmid M, Lesch KP, Beckmann H. Linkage and family-based association study of schizophrenia and the synapsin III locus that maps to chromosome 22q13. Am J Med Genet. 2000;96(3):392–7.
Article
CAS
PubMed
Google Scholar
Deken SL, Beckman ML, Quick MW. PICKing on transporters. Trends Neurosci. 2001;24(11):623–5.
Article
CAS
PubMed
Google Scholar
Haerian BS. BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis. Pharmacogenomics. 2013;14(16):2055–65.
Article
CAS
PubMed
Google Scholar
Iamjan SA, Thanoi S, Watiktinkorn P, Nudmamud-Thanoi S, Reynolds GP. BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence. Pharmacogenomics. 2015;16(14):1541–5.
Article
CAS
PubMed
Google Scholar
Cheng CY, Hong CJ, Yu YW, Chen TJ, Wu HC, Tsai SJ. Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res Mol Brain Res. 2005;140(1–2):86–90.
Article
CAS
PubMed
Google Scholar
Sim MS, Mohamed Z, Hatim A, Rajagopal VL, Habil MH. Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Res. 2010;1357:91–6.
Article
CAS
PubMed
Google Scholar
Bolanos CA, Nestler EJ. Neurotrophic mechanisms in drug addiction. Neuromolecular Med. 2004;5(1):69–83.
Article
CAS
PubMed
Google Scholar
Alam-mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: a systematic review from the most populated Persian Gulf country. Asian J Psychiatr. 2015;16:17–25.
Article
PubMed
Google Scholar
Mclellan AT. Substance misuse and substance use disorders: Why do they matter in healthcare? Trans Am Climatol Assoc. 2017;128:112.
Google Scholar
Hasin DS, O’Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834–51.
Article
PubMed
PubMed Central
Google Scholar
Mardan-Nik M, Saffar Soflaei S, Biabangard-Zak A, Asghari M, Saljoughian S, Tajbakhsh A, Meshkat Z, Ferns GA, Pasdar A, Ghayour-Mobarhan M. A method for improving the efficiency of DNA extraction from clotted blood samples. J Clin Lab Anal. 2019;33(6):e22892.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu J, Huang S, Sun M, Liu S, Liu Y, Wang W, Zhang X, Wang H, Hua W. An improved allele-specific PCR primer design method for SNP marker analysis and its application. Plant Methods. 2012;8(1):34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yoo J, Lee Y, Kim Y, Rha SY, Kim Y: SNPAnalyzer 2.0: A web-based integrated workbench for linkage disequilibrium analysis and association analysis. BMC Bioinformatics 2008, 9(1):290.
Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68(4):978–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Association AP: Diagnostic and statistical manual of mental disorders (DSM-5®): American Psychiatric Pub; 2013.
Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science. 1988;242(4879):715–23.
Article
CAS
PubMed
Google Scholar
Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Invest. 2003;111(10):1444–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M, Ma Y, Pradhan K, Wong C. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci. 2007;27(46):12700–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alammehrjerdi Z, Ezard N, Dolan K. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern. Asian J Psychiatr. 2018;31:49–55.
Article
PubMed
Google Scholar
Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013;24(6):e115-116.
Article
PubMed
Google Scholar
Ujike H: [Potential genetic predictors for individual vulnerability to substance dependence]. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 2008, 28(1):11–17.
Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI, Staudinger J, Caron MG. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron. 2001;30(1):121–34.
Article
CAS
PubMed
Google Scholar
Hanley JG, Henley JM. PICK1 is a calcium-sensor for NMDA-induced AMPA receptor trafficking. EMBO J. 2005;24(18):3266–78.
Article
CAS
PubMed
PubMed Central
Google Scholar
Perroy J, El Far O, Bertaso F, Pin JP, Betz H, Bockaert J, Fagni L. PICK1 is required for the control of synaptic transmission by the metabotropic glutamate receptor 7. EMBO J. 2002;21(12):2990–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fujii K, Maeda K, Hikida T, Mustafa AK, Balkissoon R, Xia J, Yamada T, Ozeki Y, Kawahara R, Okawa M, et al. Serine racemase binds to PICK1: potential relevance to schizophrenia. Molecular Psychiatry. 2006;11(2):150–7.
Article
CAS
PubMed
Google Scholar
D’Ascenzo M, Podda MV, Grassi C. The role of D-serine as co-agonist of NMDA receptors in the nucleus accumbens: relevance to cocaine addiction. Front Synaptic Neurosci. 2014;6(16):16.
PubMed
PubMed Central
Google Scholar
Li X, Wolf ME. Brain-derived neurotrophic factor rapidly increases AMPA receptor surface expression in rat nucleus accumbens. Eur J Neurosci. 2011;34(2):190–8.
Article
PubMed
PubMed Central
Google Scholar
Bousman CA, Glatt SJ, Cherner M, Atkinson JH, Grant I, Tsuang MT, Everall IP, Group H. Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res. 2010;178(2):295–8.
Article
CAS
Google Scholar
González-Castro TB, Salas-Magaña M, Juárez-Rojop IE, López-Narváez ML, Tovilla-Zárate CA, Hernández-Díaz Y. Exploring the association between BDNF Val66Met polymorphism and suicidal behavior: Meta-analysis and systematic review. J Psychiatr Res. 2017;94:208–17.
Article
PubMed
Google Scholar
Bousman CA, Glatt SJ, Cherner M, Atkinson JH, Grant I, Tsuang MT, Everall IP. Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res. 2010;178(2):295–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Greening DW, Notaras M, Chen M, Xu R, Smith JD, Cheng L, Simpson RJ, Hill AF, van den Buuse M: Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome. Molecular psychiatry 2019.
Ren W, Luan X, Zhang J, Gutteea P, Cai Y, Zhao J, Gu Y, Wu C, Su H, Tao J, et al. Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal. J Affect Disord. 2017;221:165–71.
Article
CAS
PubMed
Google Scholar
Heinzerling KG, McCracken JT, Swanson A-N, Ray LA, Shoptaw SJ. COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation. J Clin Psychopharmacol. 2012;32(1):135–7.
Article
PubMed
PubMed Central
Google Scholar
Gajjar TM, Anderson LI, Dluzen DE. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J Neural Transm (Vienna). 2003;110(11):1215–24.
Article
CAS
Google Scholar
Dluzen DE, McDermott JL. Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system. Ann N Y Acad Sci. 2000;914:112–26.
Article
CAS
PubMed
Google Scholar
Su H, Tao J, Zhang J, Xie Y, Sun Y, Li L, Xu K, Han B, Lu Y, Sun H, et al. An association between BDNF Val66Met polymorphism and impulsivity in methamphetamine abusers. Neurosci Lett. 2014;582:16–20.
Article
CAS
PubMed
Google Scholar
Su H, Tao J, Zhang J, Xie Y, Han B, Lu Y, Sun H, Wei Y, Wang Y, Zhang Y, et al. The analysis of BDNF gene polymorphism haplotypes and impulsivity in methamphetamine abusers. Compr Psychiatry. 2015;59:62–7.
Article
PubMed
Google Scholar
Xu X, Ji H, Liu G, Wang Q, Liu H, Shen W, Li L, Xie X, Zhou W, Duan S. A significant association between BDNF promoter methylation and the risk of drug addiction. Gene. 2016;584(1):54–9.
Article
CAS
PubMed
Google Scholar
Su H, Tao J, Zhang J, Xie Y, Wang Y, Zhang Y, Han B, Lu Y, Sun H, Wei Y, et al. The effects of BDNF Val66Met gene polymorphism on serum BDNF and cognitive function in methamphetamine-dependent patients and normal controls: a case-control study. J Clin Psychopharmacol. 2015;35(5):517–24.
Article
CAS
PubMed
Google Scholar
Itoh K, Hashimoto K, Shimizu E, Sekine Y, Ozaki N, Inada T, Harano M, Iwata N, Komiyama T, Yamada M et al: Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan. Am J Med Genet B Neuropsychiatr Genet 2005, 132b(1):70–73.
Heinzerling KG, Shoptaw S. Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use. Gend Med. 2012;9(2):112–20.
Article
PubMed
PubMed Central
Google Scholar